NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Journal of Translational Medicine
https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1507-6%20/

Among the ITT patients with a surgery date?≥?30 months prior to the data collection (n = 223), 30% (n = 67) have lived?≥?30 months, and their KM-derived mOS estimate is 46.5 months.

Sentiment,

I have a question.

Did just 67 live past 30 months? Or were 67 alive over 30 month at the time the data was taken for the journal?
And if 67 were alive at the time of the analysis why don’t we see 23 censors between month 30 and month 36? (67 – 44 = 23)

Journal of Translational Medicine

Among the ITT patients with a surgery date ≥ 36 months prior to the data collection (n = 182), 24.2% (n = 44) have lived ≥ 36 months and their KM-derived mOS estimate is 88.2 months.